In humans, both, NDRG2 and FXR mRNA's are reduced in primary hepatocellular carcinoma samples of different tumor stages compared to normal human liver or non-HCC liver diseased human liver. The gene discussed is NR1H4; the disease is hepatocellular carcinoma.